Skip to main content
[Preprint]. 2024 Sep 22:2024.09.19.24313985. [Version 1] doi: 10.1101/2024.09.19.24313985

Table 1.

Number (%) of clinical isolates sequenced that were determined to belong to an outbreak (as defined in Methods), by bacterial species, November 2021 – November 2023

Organism Collected Unique Patients No. in Outbreak (%) No. Outbreaks

Acinetobacter species 121 115 22 (19.1) 9

Burkholderia species 26 16 0 (0) 0

Citrobacter species 92 81 4 (4.9) 2
Clostridioides difficile 251 245 19 (7.8) 7
Enterobacter cloacae 88 79 9 (11.4) 4
Escherichia coli, ESBL producing 291 246 22 (8.9) 9

Klebsiella oxytoca 48 45 4 (8.9) 2

Klebsiella pneumoniae, ESBL producing 247 188 55 (29.3) 19
Legionella species 0 0 0 (0 0
Methicillin-resistant Staphylococcus aureus 656 573 52 (9.1) 23
Proteus mirabilis 556 463 21 (4.5) 9

Providencia species 70 63 2 (3.2) 1

Pseudomonas aeruginosa 1379 1029 114 (11.1) 44
Pseudomonas species, not aeruginosa 58 57 2 (3.5) 1
Raoultella species 2 2 0 (0) 0
Serratia marcescens 347 282 15 (5.3) 7

Stenotrophomonas maltophilia 252 211 13 (6.2) 6
Vancomycin-resistant Enterococcus faecalis 4 4 0 (0) 0
Vancomycin-resistant 240 228 122 (53.5) 29

Enterococcus faecium
Total 4723 3921 476 (12.1) 172

ST: Sequence type; ESBL: Extended-spectrum beta-lactamase